1. Targeting the miR-6734-3p/ZEB2 axis hampers development of non-small cell lung cancer (NSCLC) and increases susceptibility of cancer cells to cisplatin treatment. Issue 1 (1st January 2021) Authors: Wei, Linying; Jiang, Jianyang Journal: Bioengineered Issue: Volume 12:Issue 1(2021) Page Start: 2499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗